Epizyme, Inc. 3 SEC Filings

Filed On	Filing
21 Mar 2022	Form 3: Korn Jerald, Chief Operating Officer No securities owned
09 Feb 2022	Form 3: Royalty Pharma Investments 2019 Icav, Director Holds 22,666,667 shares of Common Stock
18 Nov 2021	Form 3: BEVERIDGE, Roy A, Director No securities owned
18 Nov 2021	Form 3: Stuckley Carol, Director No securities owned
28 Sep 2020	Form 3: Vakiener Victoria, Chief Commercial Officer Holds 26,867 shares of Common Stock
03 Apr 2020	Form 3: Kutok Jeffery, Chief Scientific Officer No securities owned
08 Nov 2019	Form 3: Legorreta Pablo G., Director and 2 others Holds 6,666,667 shares of Common Stock
04 Sep 2019	Form 3: Bogle Grant C., Director No securities owned
04 Sep 2019	Form 3: Richon Victoria, Director Holds 5,554 shares of Common Stock, par value $0.0001
21 Aug 2019	Form 3: Tombesi Paolo, Chief Financial Officer No securities owned
25 Jan 2019	Form 3: Beaulieu Joseph, Corporate Controller
24 Jul 2018	Form 3: Agarwal Shefali, Chief Medical Officer No securities owned
12 Mar 2018	Form 3: Giordano Michael F, Director No securities owned
21 Sep 2017	Form 3: Fleming Suzanne, SVP No securities owned
07 Feb 2017	Form 3: Conroy Kevin T, Director No securities owned
17 May 2016	Form 3: Ros Matthew, Chief Operating Officer No securities owned
26 Apr 2016	Form 3: Graf Susan E, Chief Business Officer No securities owned
14 Sep 2015	Form 3: Bazemore Robert B, Director
11 Feb 2015	Form 3: Singer Andrew E., EVP & CFO Holds 0 shares of No securities are beneficially owned
12 Dec 2014	Form 3: Bate Kenneth, Director Holds 0 shares of No securities are beneficially owned

Comments